Laboratory of Neurogenomiks
![Foto de Laboratory of Neurogenomiks](/img/grupo.png)
![Foto de Hospital Nacional de Parapléjicos](/img/noimage_org.png)
Hospital Nacional de Parapléjicos
Toledo, EspañaPublications in collaboration with researchers from Hospital Nacional de Parapléjicos (2)
2022
-
GABAB receptor agonist baclofen promotes central nervous system remyelination
GLIA, Vol. 70, Núm. 12, pp. 2426-2440
2020
-
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430